Страна: Австралия
Език: английски
Източник: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CLOSTRIDIUM BOTULINUM TYPE D TOXOID; CLOSTRIDIUM BOTULINUM TYPE C; THIOMERSAL
ZOETIS AUSTRALIA PTY LTD
Cl botulinum type C+Cl botulinum type D
MISC. VACCINES OR ANTI SERA
CLOSTRIDIUM BOTULINUM TYPE D TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM BOTULINUM TYPE C VACCINE-TOXOID Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml
!200x2.5mL; !500mL; !500x1mL; #100x2.5mL; #250mL; #250x1mL; *25x500mL; *5000x2.5; ^100mL; ^100x1mL; ^40x2.5mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CATTLE | SHEEP | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | EWE | HEIFER | H
IMMUNOTHERAPY
BOTULISM
Poison schedule: 0; Withholding period: WHP: MEAT: NIL MILK: NIL EXPORT SLAU GHTER INTERVAL (ESI): ESI not applicabl e.; Host/pest details: CATTLE: [BOTULISM]; SHEEP: [BOTULISM]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [BOTULISM]; SHEEP: [BOTULISM]; For the prevention of botulism in cattle and sheep.
Registered
2023-07-01
APPENDIX2 Australian Government Australian Pestiddes and Veterinary Medicines Authority TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPs) (Veterinary Products) Select appropriate: [J New Product (include all applicable RLPs) OR IRI Variation (highlight instructions that are being varied}. Approval no. of label being varied: 59537/1 [2,3]/0509 Signal heading: Product name: Active constituent/s: Statement of claims: Net contents: Directions for Use Heading: Restraints: Contraindications: Precautions: Side effects: Dosage & administration: FOR ANIMAL TREATMENT ONLY Ultravac® Botulinum Vaccine Cl. botulinum type C <: 5 IU/mL, C/. botulinum type D ;;, 1.0 IU/mL (toxoids). 0.1 mg/mL Thiomersal added as an antiseptic For the prevention of botulism in cattle and sheep. 1 OOmL, 250 mL and 500 mL DIRECTIONS FOR USE READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT Shake well before use and keep thoroughly mixed during use This product can be stored and used for up to 30 days after first opening Handle aseptically and store refrigerated and protected from light Please refer to the resealing section and the product insert for further information on storage and handling after opening It is important that the vaccine is kept properly mixed before and during use. The ro""' of '"~•l•tioo I• ~"'"'""•oo• U••l ""'•' '* N/A N/A -... Take care to avoid self-injection A RLP ~ Localised swelling may develop at the site of injection and a firm, nodular lump may persist for some weeks, even months. This product can be stored and used for up to 30 days after first opening The route of inoculation is subcutaneous Uust under the recommended site for injection is high on the neck, behind the ear. The recommended dose for cattle of all ages is 2.5 mL, and for 18 Wormald Street, Symonston ACT 2609 PO Box 6182, Kingston ACT 2604 Australia Tel: +61 2 6210 4700 Fax: +61 2 6210 4874 www.apvma.gov.au ABN 19 495 043 447 skin). The of all ' General directions: ages is 1 mL. One dose of vaccine is sufficient to confer protection in are Прочетете целия документ
PRODUCT NAME: ULTRAVAC ® BOTULINUM VACCINE PAGE: 1 OF 5 THIS REVISION ISSUED: APRIL, 2010 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: (02)9850 3333 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: (02) 9850 3333 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 SUBSTANCE: Aqueous suspension of _Clostridium botulinum_ Types C & D Toxoids. TRADE NAME: ULTRAVAC ® BOTULINUM VACCINE PFIZER MSDS CODE: 0053 PRODUCT USE: Animal vaccine for the prevention of botulism in cattle as described on the product label. CREATION DATE: JUNE, 2004 THIS VERSION ISSUED: APRIL, 2010 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Aqueous suspension. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S INHALATION SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazar Прочетете целия документ